Brief validation of the novel GeneXpert Xpress SARS-CoV-2 PCR assay

The clinical and epidemiologic management of the SARS-CoV-2 pandemic is critically dependent on molecular assays with short turn-around time. We validated the novel Xpert Xpress SARS-CoV-2 assay using a commercial nucleic acid testing (Roche Cobas 6800). We found an excellent concordance over a rang...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldenberger, Daniel, Leuzinger, Karoline, Sogaard, Kirstine K., Gosert, Rainer, Roloff, Tim, Naegele, Klaudia, Cuénod, Aline, Mari, Alfredo, Seth-Smith, Helena, Rentsch, Katharina, Hinić, Vladimira, Hirsch, Hans H., Egli, Adrian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351036/
https://www.ncbi.nlm.nih.gov/pubmed/32659240
http://dx.doi.org/10.1016/j.jviromet.2020.113925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351036/
https://www.ncbi.nlm.nih.gov/pubmed/32659240
http://dx.doi.org/10.1016/j.jviromet.2020.113925

Ejemplares similares